EGFR and breast cancer: 27 In the present study, using the GPER-positive and ER-negative SkBr3 breast cancer cells and CAFs obtained from breast cancer patients, we demonstrate that estrogens upregulate SIRT1 expression through the GPER/EGFR/ERK/c-fos/AP-1 transduction pathway.